3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
16
Neoplasms
4
Neoplasm Metastasis
4
Prostatic Neoplasms
3
Multiple Myeloma
3
Giant Cell Tumor of Bone
3
Carcinoma, Renal Cell
3
Smoldering Multiple Myeloma
2
Recurrence
2
Osteoporosis
2
Melanoma
2
Kidney Neoplasms
2
Bone Cysts, Aneurysmal
2
With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Thyroid Cancer Metastatic
1
Parathyroid Neoplasms
1
Osteoporotic Fractures
1
Osteopetrosis, mild autosomal recessive form
1
Osteopetrosis, Autosomal Recessive 7
1
Osteoblastoma
1
Neoplastic Cells, Circulating
1
Musculoskeletal Pain
1
Mastocytosis, Systemic
1
Lung Neoplasms
1
Inflammatory Breast Neoplasms
1
Hyperparathyroidism, Primary
1
Granuloma, Giant Cell
1
Giant Cell Tumors
1
Interventions
Letrozole
4
Anastrozole
4
Surveys and Questionnaires
3
Aromatase Inhibitors
3
exemestane
2
Exercise
2
Educational Status
2
Acupuncture Therapy
2
methyl hydroxyethyl cellulose
1
guizhi-shaoyao-zhimu decoction
1
Yoga
1
Walking
1
Vitamin B 12
1
Therapeutics
1
Testosterone
1
Tamoxifen
1
Occupational Therapy
1
Hyaluronic Acid
1
Glucosamine
1
Glucaric Acid
1
Gabapentin
1
Fish Oils
1
Fatty Acids, Omega-3
1
Docosahexaenoic Acids
1
Diphosphonates
1
Diet Therapy
1
Denosumab
1
Curcumin
1
Chondroitin Sulfates
1
Chondroitin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Arthralgia
×
Denosumab
×
Clear all
NCT03811509
2019-01-28
B-ABLE
Parc de Salut Mar
Phase 4
Unknown
1,000 enrolled